30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Burke Steven Keith

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Burke Steven Keith's trades of Akebia Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-02
PlS Planned sale
12,266 +7.2%
328.74
US$1,922,656 		12,266 +7.2% 328.74 US$1,922,656
2026-02-04 2026-02-02
PlS Planned sale
26,472 +3.5%
455.92
US$1,654,712 		26,472 +3.5% 455.92 US$1,654,712
2026-02-04 2026-02-02
PlS Planned sale
14,278 +0.6%
235.11
US$2,195,974 		14,278 +0.6% 235.11 US$2,195,974
2026-02-04 2026-02-02
PlS Planned sale
25,375 -2.6%
1.39
US$35,271 		25,375 -2.6% 1.39 US$35,271
2026-02-04 2026-02-02
PlS Planned sale
21,582 -2.1%
1.39
US$29,999 		21,582 -2.1% 1.39 US$29,999
2026-02-02 2026-02-02
PrS Proposed sale
67,658
1.39
US$94,349 		67,658 1.39 US$94,349
2025-03-04 2025-03-03
PlS Planned sale
7,144 -0.9%
1.83
US$13,074 		7,144 -0.9% 1.83 US$13,074
2025-03-03 2025-03-03
PrS Proposed sale
7,144
1.83
US$13,086 		7,144 1.83 US$13,086
2025-02-04 2025-02-03
PlS Planned sale
27,236 -3.2%
2.10
US$57,196 		27,236 -3.2% 2.10 US$57,196
2025-02-04 2025-02-03
PlS Planned sale
23,270 -2.7%
2.10
US$48,867 		23,270 -2.7% 2.10 US$48,867
2025-02-03 2025-02-03
PrS Proposed sale
50,506
2.10
US$106,295 		50,506 2.10 US$106,295
2024-03-01 2024-02-29
S Sale
7,169 -1.0%
1.58
US$11,327 		7,169 -1.0% 1.58 US$11,327
2024-02-29 2024-02-29
PrS Proposed sale
7,169
1.58
US$11,301 		7,169 1.58 US$11,301
2024-02-29 2024-02-27
PlS Planned sale
8,367 -1.2%
1.52
US$12,718 		8,367 -1.2% 1.52 US$12,718
2024-02-27 2024-02-27
PrS Proposed sale
8,367
1.52
US$12,695 		8,367 1.52 US$12,695
2024-02-02 2024-02-01
S Sale
24,311 -3.3%
1.68
US$40,842 		24,311 -3.3% 1.68 US$40,842
2024-02-01 2024-02-01
PrS Proposed sale
24,311
1.68
US$40,767 		24,311 1.68 US$40,767
2024-05-09 2023-08-25
S Sale
27,000 -3.9%
1.15
US$31,050 		27,000 -3.9% 1.15 US$31,050
2023-05-18 2023-05-16
S Sale
63,567 -10.7%
1.07
US$67,890 		63,567 -10.7% 1.07 US$67,890
2023-05-16 2023-05-16
PrS Proposed sale
63,567
1.07
US$67,890 		63,567 1.07 US$67,890
2023-03-03 2023-03-01
S Sale
1,110 -0.2%
0.88
US$974 		1,110 -0.2% 0.88 US$974
2023-03-03 2023-03-01
S Sale
6,400 -1.1%
0.88
US$5,616 		6,400 -1.1% 0.88 US$5,616
2023-03-03 2023-03-01
S Sale
6,613 -1.1%
0.88
US$5,803 		6,613 -1.1% 0.88 US$5,803
2023-03-01 2023-02-27
S Sale
7,539 -1.2%
0.81
US$6,131 		7,539 -1.2% 0.81 US$6,131
2022-09-01 2022-08-31
PlS Planned sale
1,147 -0.3%
0.36
US$416 		1,147 -0.3% 0.36 US$416
2022-03-02 2022-03-01
PlS Planned sale
1,100 -0.5%
2.17
US$2,388 		1,100 -0.5% 2.17 US$2,388
2022-03-02 2022-03-01
S Sale
6,556 -2.9%
2.17
US$14,231 		6,556 -2.9% 2.17 US$14,231
2022-03-02 2022-02-28
S Sale
7,400 -4.3%
2.15
US$15,946 		7,400 -4.3% 2.15 US$15,946
2021-04-01 2021-04-01
S Sale
1,081 -0.6%
3.40
US$3,675 		1,081 -0.6% 3.40 US$3,675
2021-03-02 2021-03-01
S Sale
7,558 -4.5%
3.40
US$25,668 		7,558 -4.5% 3.40 US$25,668